Latest period
$92.50B
YoY change
-1.4%
5Y CAGR
+7.6%
Peak year (2023)
$97.15B
Latest annual
$90.59B
Total Assets history chart for Amgen (AMGN) from 1985 to 2025
Latest: $90.59B
Total Assets growth chart for Amgen (AMGN) from 1985 to 2025
Latest: -1.4%
Total Assets history table for Amgen (AMGN) from 1985 to 2025
| 2025 | $90.59B | -1.4% | −$1.25B | ||
| 2024 | $91.84B | -5.5% | −$5.32B | ||
| 2023 | $97.15B | +49.2% | +$32.03B | ||
| 2022 | $65.12B | +6.5% | +$3.96B | ||
| 2021 | $61.16B | -2.8% | −$1.78B | ||
| 2020 | $62.95B | +5.4% | +$3.24B | ||
| 2019 | $59.71B | -10.1% | −$6.71B | ||
| 2018 | $66.42B | -16.9% | −$13.54B | ||
| 2017 | $79.95B | +3.0% | +$2.33B | ||
| 2016 | $77.63B | +8.5% | +$6.05B | ||
| 2015 | $71.58B | +3.7% | +$2.57B | ||
| 2014 | $69.01B | +4.4% | +$2.88B | ||
| 2013 | $66.13B | +21.8% | +$11.83B | ||
| 2012 | $54.30B | +11.1% | +$5.43B | ||
| 2011 | $48.87B | +12.4% | +$5.38B | ||
| 2010 | $43.49B | +9.7% | +$3.86B | ||
| 2009 | $39.63B | +8.7% | +$3.19B | ||
| 2008 | $36.44B | +5.2% | +$1.80B | ||
| 2007 | $34.64B | +2.5% | +$851.00M | ||
| 2006 | $33.79B | +15.3% | +$4.49B | ||
| 2005 | $29.30B | +0.3% | +$76.00M | ||
| 2004 | $29.22B | +11.6% | +$3.04B | ||
| 2003 | $26.18B | +7.0% | +$1.72B | ||
| 2002 | $24.46B | +279.6% | +$18.01B | ||
| 2001 | $6.44B | +19.3% | +$1.04B | ||
| 2000 | $5.40B | +32.4% | +$1.32B | ||
| 1999 | $4.08B | +11.0% | +$405.40M | ||
| 1998 | $3.67B | +18.1% | +$562.00M | ||
| 1997 | $3.11B | +12.5% | +$344.60M | ||
| 1996 | $2.77B | +13.7% | +$332.80M | ||
| 1995 | $2.43B | +22.0% | +$438.70M | ||
| 1994 | $1.99B | +12.9% | +$228.60M | ||
| 1993 | $1.77B | +28.5% | +$391.20M | ||
| 1992 | $1.37B | +58.8% | +$508.80M | ||
| 1991 | $865.50M | +68.4% | +$351.50M | ||
| 1990 | $514.00M | — | — | ||
| 1988 | $207.10M | +7.4% | +$14.30M | ||
| 1987 | $192.80M | +99.2% | +$96.00M | ||
| 1986 | $96.80M | +3.3% | +$3.10M | ||
| 1985 | $93.70M | — | — |
- 2025$90.59B-1.4%
- 2024$91.84B-5.5%
- 2023$97.15B+49.2%
- 2022$65.12B+6.5%
- 2021$61.16B-2.8%
- 2020$62.95B+5.4%
- 2019$59.71B-10.1%
- 2018$66.42B-16.9%
- 2017$79.95B+3.0%
- 2016$77.63B+8.5%
- 2015$71.58B+3.7%
- 2014$69.01B+4.4%
- 2013$66.13B+21.8%
- 2012$54.30B+11.1%
- 2011$48.87B+12.4%
- 2010$43.49B+9.7%
- 2009$39.63B+8.7%
- 2008$36.44B+5.2%
- 2007$34.64B+2.5%
- 2006$33.79B+15.3%
- 2005$29.30B+0.3%
- 2004$29.22B+11.6%
- 2003$26.18B+7.0%
- 2002$24.46B+279.6%
- 2001$6.44B+19.3%
- 2000$5.40B+32.4%
- 1999$4.08B+11.0%
- 1998$3.67B+18.1%
- 1997$3.11B+12.5%
- 1996$2.77B+13.7%
- 1995$2.43B+22.0%
- 1994$1.99B+12.9%
- 1993$1.77B+28.5%
- 1992$1.37B+58.8%
- 1991$865.50M+68.4%
- 1990$514.00M—
- 1988$207.10M+7.4%
- 1987$192.80M+99.2%
- 1986$96.80M+3.3%
- 1985$93.70M—
Total Assets values are taken from Amgen's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's latest reported total assets is $92.50B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Amgen (AMGN) total assets is $90.59B – edged down 1.4% year-over-year.
Amgen total assets compound annual growth for the 2020–2025 (5 years) window is +7.6%, with mixed annual results across the window.
Amgen total assets declined from $97.15B in 2023 to $90.59B in 2025, a 6.8% drawdown.
$97.15B stands as the all-time-high annual total assets, posted in 2023, against a low of $93.70M during 1985.
Amgen Total Assets by Year
Amgen Total Assets 2025: $90.59B
In 2025, Amgen reported total assets of $90.59B, edged down 1.4% below 2024.
Amgen Total Assets 2024: $91.84B
Amgen total assets in 2024 was $91.84B, declined 5.5% below 2023.
Amgen Total Assets 2023: $97.15B
2023's total assets for Amgen came in at $97.15B, surged 49.2% from 2022. This figure represents the highest annual value in the available history.
Amgen Total Assets 2022: $65.12B
Amgen posted total assets of $65.12B in 2022, grew 6.5% from 2021.
Amgen Total Assets 2021: $61.16B
Amgen total assets in 2021 was $61.16B.
See more financial history for Amgen (AMGN).
Sector peers by Total Assets
Healthcare peers of Amgen (AMGN), ranked by their latest total assets
| $309.58B | |
| $199.21B | |
| $136.87B | |
| $133.96B | |
| $114.07B | |
| $112.48B | |
| $110.34B | |
| $85.37B |
- $309.58B
- $199.21B
- $136.87B
- $133.96B
- $114.07B
- $112.48B
- $110.34B
- $85.37B
Frequently asked questions
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation